Authors

• Zhihong Cheng (ORCID: https://orcid.org/0000-0003-0311-8787)
• Dongni Chen
• Rong Qin (ORCID: https://orcid.org/0009-0000-7802-9418)
• Shaoli Zuo
• Rui Chen (ORCID: https://orcid.org/0000-0002-0309-8969)
• Yingying Gu
• Junhao Huang (ORCID: https://orcid.org/0000-0002-9275-3741)
• Manting Liu (ORCID: https://orcid.org/0009-0004-7163-186X)
• Bingjia He
• Ankui Yang (ORCID: https://orcid.org/0000-0002-8534-3883)
• Rom S. Leidner (ORCID: https://orcid.org/0000-0003-0788-7938)
• Tianrun Liu (ORCID: https://orcid.org/0000-0002-9049-2197)
• Hui Lian (ORCID: https://orcid.org/0000-0002-1191-0435)
• Qingde Wu
• Tianheng Li (ORCID: https://orcid.org/0000-0001-8530-6831)
• Min Li (ORCID: https://orcid.org/0000-0002-7113-2700)
• Zhenfeng Zhang (ORCID: https://orcid.org/0000-0001-5621-9755)
• Lili Yang
• Hainan Yang (ORCID: https://orcid.org/0000-0001-6864-1478)
• Xufeng Li (ORCID: https://orcid.org/0009-0007-3366-8073)
• Neelam Shah
• H Tan (ORCID: https://orcid.org/0009-0006-2245-4953)
• Yuanjun Ou

Institutions

• Guangzhou University of Chinese Medicine (CN)
• Sun Yat-sen University (CN)
• Providence Portland Medical Center (US)
• Second Affiliated Hospital of Guangzhou Medical University (CN)
• Sun Yat-sen Memorial Hospital (CN)
• Foshan Hospital of TCM (CN)
• Sun Yat-sen University Cancer Center (CN)
• State Key Laboratory of Oncology in South China
• Guangzhou Medical University (CN)

Publication Details

Journal

Frontiers in Immunology

Published

2025-12-12

DOI

https://doi.org/10.3389/fimmu.2025.1669924

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

0.00